Press release
Next-Generation Antibody Therapeutics Market and its Growth Landscape for the Next Few Years
Explore report sample at: https://www.psmarketresearch.com/market-analysis/next-generation-antibody-market/report-sample
Governments of various countries are involved in taking initiatives for improving healthcare facilities, and making next-generation antibody therapeutics affordable. This is increasing the demand for next-generation antibody therapeutics. The increasing global gross domestic product (GDP) and growing healthcare expenditure have created a positive impact on the growth of the next-generation antibody therapeutics market. Also, in comparison to traditional antibodies, the next-generation antibody therapeutics is more effective in the treatment of various diseases, such as cancer, autoimmune disorders, and inflammatory diseases. This is attracting various pharmaceutical and biotechnology companies to increase their investment in the R&D of next-generation antibody therapeutics.
Browse report at: https://www.psmarketresearch.com/market-analysis/next-generation-antibody-market
The key companies operating in the global next-generation antibody therapeutics market include Seattle Genetics Inc., F. Hoffmann-La Roche Ltd, ImmunoGen Inc., Pfizer Inc., Amgen Inc., Biogen, Kyowa Hakko Kirin Co. Ltd., Bristol-Myers Squibb Company, Xencor Inc., AstraZeneca PLC., Dyax Corp., Takeda Pharmaceuticals Company Limited and Bayer AG.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Next-Generation Antibody Therapeutics Market and its Growth Landscape for the Next Few Years here
News-ID: 1196570 • Views: …
More Releases from P&S Intelligence - Biotechnology
Surgical Navigation System Market 2023 by key Players Stryker, OrthAlign, Inc., …
Global surgical navigation system market is forecasted to attain revenues of $1046.8 million value by 2023. The growth in the market will be led by the rising prevalence of orthopedic, neurological, and ENT disorders, increasing adoption of minimally invasive surgical procedures, rising aging population, technological advancements, and increasing regulatory approval for navigation systems, that can be used in various surgeries.
Browse report sample at: https://www.psmarketresearch.com/market-analysis/surgical-navigation-system-market/report-sample
*Key competitors in the market are collaborating…
High-Throughput Screening Market 2023 by Key Players Analysis Agilent Technologi …
The global high-throughput screening market is witnessing considerable growth due to increasing geriatric population, increasing healthcare expenditure, increasing research and development activities, launch of technologically advanced products that are miniaturized and automated and growing popularity of high-throughput screening for drug discovery. Moreover, high adoption of high-throughput screening models in pharmaceutical and biotechnology companies across the globe is supporting the growth of the market. Based on technology, 2D cell culture segment…
Cell Isolation Market Survey and In-depth Analysis on Industry Growth Factors, T …
Global cell isolation market size is expected to reach $12.6 billion by 2023. The market is mainly driven by rising demand for biopharmaceuticals, increasing government funding for cell-based research, and growing research on personalized medicine.
Explore report sample at: https://www.psmarketresearch.com/market-analysis/cell-isolation-market/report-sample
Based on product, the cell isolation market is categorized into consumables and instruments. Consumables generated revenue of more than $2.5 billion, accounting for 61.4% share, in the market in 2017, owing to…
Oligonucleotide Synthesis Market Overview, Size, Share, Growth Drivers and Forec …
Global oligonucleotide synthesis market is expected to reach $2.8 billion by 2023, according to P&S Intelligence.
The market is mainly driven by advancements in oligonucleotide synthesis technologies, favorable government regulations, growing research activities in synthetic biology, and rising prevalence of cancer and infectious diseases.
Explore report sample at: https://www.psmarketresearch.com/market-analysis/oligonucleotide-synthesis-market/report-sample
Based on offering, the oligonucleotide synthesis market is classified into synthesized oligonucleotides, reagents and consumables, and equipment. During the historical period, synthesized oligonucleotides held…
More Releases for R&D
Siveco doubles China R&D investment
On July 3, 2019, Siveco China held its half-year management meeting at the prestigious Hellas House in Shanghai, a nod to the company's continuing growth on the Belt & Road. With financial results above target, high customer satisfaction (as shown in the latest audited customer satisfaction survey) and a sales pipeline more promising than ever, the company's management board announced that shareholders have approved its request for additional investment in…
R&D Collaborative Projects by GD Rectifiers
GD Rectifiers have extensive experience in collaborative R&D projects and are proud to work with some of the UK’s pioneering power electronic companies to drive design and innovation forward.
This R&D service helps drive GD Rectifiers forward as a cutting edge manufacturer embracing fundamental technologies that support product development that contribute to next generation products throughout: renewable energy, embedded systems, smart metrering and the rail industry.
Power Assemblies, Controllers and…
Transforming Pharmaceutical R&D with Data
ReportsWorldwide has announced the addition of a new report title Transforming Pharmaceutical R&D with Data to its growing collection of premium market research reports.
Transforming Pharmaceutical R&D with Data
In the current drug pricing environment, biopharmaceutical firms cannot afford to continue spending billions of dollars on development programs that are more than 90% likely to fail. Raising prices to compensate for expensive, risky research and development (R&D) is no longer an option…
Noliac is expanding the R&D team
Noliac is looking for two new colleagues for the R&D team in Prague, Czech Republic: A Precision/Fine Mechanics and an Electroengineer.
Precision/Fine Mechanics
For the R&D team in Prague, Czech Republic, Noliac is looking for a Precision/Fine mechanics to work on modifying existing products and work with developing new. Noliac requires a colleague who:
Is mechanically skilled with a focus on very small machinery.
Holds a technical high school degree or an apprenticeship…
Leiber GmbH further invests in R&D
Since February 2016, Leiber GmbH has been reinforced by Dr med vet Claudia Westfahl - a veterinarian specialized in animal nutrition - as part of the company's strategy to invest in new product developments. With the new position ‘Product Development Animal Nutrition’, Dr Westfahl is responsible for new product development in the field of functional feed ingredients for both pet as well as farm animals. After graduating at the University…
Rising R&D Funding for Nanotechnology
Global nanotechnology market has been registering marked increase in funds allocation by the countries across the world, especially with new product development that received huge momentum due to these funding. An increase in global public funding for R&D initiatives supports quick commercialization of nano-based products. Fundings from governments, corporations, and venture capital exhibited a CAGR growth of 1% during 2008-2012. In future, it is expected that nanotechnology funding will grow…
